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CASE REPORT
Abstract—Patients with diabetes mellitus are at increased risk
of angiopathy, neuropathy and infection compared with healthy
individuals and this may lead to foot disorders. Treatment is
difficult, challenging and — if unsuccessful — often leads to
lower limbs amputations.
We present a case report of a 63-year-old man after amputation
of the big toe and part of metatarsus due to diabetic foot
syndrome, successfully treated with negative pressure wound
therapy in combination with silver dressings. The literature
regarding this issue was also reviewed.
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I. INTRODUCTION
PATIENTS with diabetes mellitus (DM) are at increasedrisk of angiopathy and neuropathy compared with healthy
individuals and that may lead to diabetic foot syndrome (DFS)
development. Foot ulceration, infection and gangrene in the
course of DFS are significant complications of the disease and
main cause of hospitalization.1 Moreover, foot disorders are
the leading cause of nontraumatic amputation and can be 15 to
40 times more frequent among the diabetic versus nondiabetic
population. The 5-year survival rate after a diabetes-related
lower limb amputation has been reported to be approximately
30%2 what is lower than in some neoplastic diseases.3, 4
Recently the negative pressure wound therapy (NPWT)
received recognition in the treatment of acute and chronic
wounds. NPWT can be used to cure various types of wounds
associated with diabetic lower extremity disease. It can be ap-
plied to a chronic diabetic foot ulcers (DFU), non-respondent
to alternative therapies and also wounds in the diabetic limbs
after surgical debridement or partial amputation.5, 6
The use of negative pressure in conjunction with silver
provides an important evolution in NPWT concept with the
potentially added profit of supplying an antimicrobial agent
to the infected wound bed.7 This article describes our idea
of treatment the patient with diabetic foot syndrome, using
NPWT in combination with silver dressing.
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II. CASE REPORT
A 63-year-old man was admitted to our ward due to necrosis
of the left big toe and foot phlegmon in the course of DFS.
Aside from diabetes mellitus patient suffered also from the
end stage renal disease and required hemodialysis. In his past
medical history, he underwent the amputation of his right leg
below knee level in 1998 however prosthetic leg allowed him
to walk. In 1999, he received the kidney transplant but the
donated organ was rejected 13 years later.
At the moment of admission the patient was in fair general
condition, with fever of 38.5◦C. The physical examination
revealed necrosis of the left big toe and massive inflammation
of the medial site of the metatarsus with fluctuance (University
of Texas Classification System — III-D).
Laboratory studies showed features of inflammatory re-
sponse: leukocytosis with left shift and elevated C-reactive
protein. The ankle-brachial index was 0.8. The radiogram
revealed a decreased density of foot bones and small lytic
lesions of big toe phalanges.
Intravenous cefuroxime was started empirically. Antibi-
otic regimens were changed considering the culture results.
ciprofloxacin was administered for Citrobacter freundii in
appropriate doses according to the results of antibiogram test.
On the day of admission, the amputation of the big toe,
debridement, and drainage were performed. Operating surgeon
had to remove necrotic tissues of the medial plantar space with
significant part of the first metatarsal bone. On the fourth day
of hospitalization, the patient was re-operated on to remove
persistent necrotic tissues (Fig. 1a and b). From the fifth day,
we started the negative pressure wound therapy.
The wound was lined with a layer of silver-containing dress-
ing (Atrauman Ag - non-adherent, polyester tulle, impregnated
with neutral triglycerides and silver ions, PAUL HARTMANN
AG, Germany) and then the NPWT polyurethane foam (Vi-
vanoMed Foam, PAUL HARTMANN AG, Germany) was
applied on it (Fig. 1c–e). The pump was set to a continuous
negative pressure of −120mmHg. Dressings were changed
every second day. After 48 hours, the pressure mode was
switched to intermittent negative pressure at −120mmHg
/−20mmHg. (Fig. 1f, g)
After 18 days of NPWT therapy (9 dressing changes) the
wound was determined to be clean by clinical assessment
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Figure 1. a) the wound after amputation of big toe and removal of necrotic tissues of the medial planar space, before the second debridement; b) the wound
after debridement; c) wound before application of NPWT; d, e) the wound lined with a layer of silver-containing dressing and then polyurethane foam; f) the
wound after 8 days negative pressure therapy; g) after 12 days; h) the wound’s bed filled with granulation tissue after 18 days of NPWT.
and adequate granulation tissue formation was achieved (Fig.
1h), the meshed split-thickness skin grafts were applied (Fig.
2a). The Atrauman Ag was used as a primary dressing for
skin grafts and covered with NPWT dressing kit with the
continuous negative pressure of −85mmHg (Fig. 2b, c). The
NPWT dressings were changed on the third day after grafts
application. We removed only the polyurethane foam, however,
the primary dressing (Atrauman Ag) remained untouched (Fig.
2d). The whole dressing (NPWT and polyester tulle with silver
ions) was changed on the 5th day after grafts application
(Fig. 2e). Approximately 95% of grafts surface was vital.
Negative pressure wound therapy was continued until it was
considered that the graft’s uptake was completed (3 NPWT
dressing changes after grafts application were administered
in total). The patient was released from the hospital on the
32nd day of treatment (Fig. 2f). The patient was examined on
weekly follow-up visits after discharge (Fig. 2g).
III. DISCUSSION
The negative pressure wound therapy (NPWT) sometimes
referred to as vacuum-assisted closure (VAC), subatmospheric
pressure dressing (SPD) or topical negative pressure (TNP)
has revolutionized wound care over the last years.8
The accurate mechanism of NPWT action is not clear,
however, it gives the number of beneficial clinical effects.9 It
creates a moist environment, improves fluid removal, reduces
tissue oedema, contracts the wound, mechanically stimulates
the wound bed, induces cell proliferation, alters blood flow in
the wound edges, stimulates neoangiogenesis and the forma-
tion of granulation tissue.9–13
The effect of NPWT on bacterial colonization of wounds
is controversial. On one hand sealed environment created by
airtight film goes against traditional wisdom with regard to the
management of infected wound with free drainage.14 On the
other, the suction device may improve bacterial clearance.15
Studies have shown that removing bacteria from the wound
is important because bacterial colonization delays or prevents
wound healing.16
In 1997, Morykwas and Argenta demonstrated that appli-
cation of negative pressure to infected experimental porcine
wounds reduced bacterial numbers significantly compared to
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Figure 2. a), b), c) application of meshed split-thickness skin grafts covered with silver impregnated dressing and NPWT; d) first dressing change after grafts’
application, polyurethane foam was removed, the primary dressing stayed untouched; e) 5th day after grafts’ application; f) the wound at the moment of
discharge from the hospital; h) the wound 3 weeks after discharge from the hospital.
traditional dressing. This evidence has become the basis for
the widespread belief that VAC contributes towards bacterial
clearance of infected wounds. However, none of the clinical
research published to date has confirmed those results.17 Some
researchers reported no change18 other even an increase19, 20 in
bacterial number in the course of NPWT, despite good clinical
outcomes.
Due to those controversies the new concept of NPWT
therapy has appeared which tries to confer more active an-
timicrobial properties on the wound. These include gauze con-
taining polyhexamethylene biguanide,21 topical irrigation with
antimicrobial solution,22 antimicrobial dressing as a wound
contact layer23 or silver impregnated NPWT foam.24 A number
of studies have reported good clinical outcomes in the presence
of these antimicrobial devices.17, 22 However, no studies have
compared the real effect of all these methods on bacterial
colonization.
In our case, we used polyester tulle, impregnated with
neutral triglycerides and silver ions as a wound contact layer
and as a primary dressing covering skin grafts. The usefulness
of silver as an antimicrobial agent has been known since
antiquity and is well established in the literature.25 It has
a broad spectrum of antibacterial, antifungal and antiviral
activity and it is routinely used as a topical dressing for
burns and chronic wounds. Its usage has increased during
the last years, perhaps because of the increased level of
bacterial resistance to traditional antibiotics.26 Therefore, the
additional antimicrobial effect in the local environment might
be crucial for the elimination of bacteria in critically col-
onized or infected wounds. Silver resistant organisms have
been reported but are extremely rare due to silver’s multiple
target sites.27 The antimicrobial effect of silver is mediated
by the presence of the highly reactive Ag+ cation which is
disruptive to many aspects of microorganism’s metabolism.
The mechanisms of action include increase in production
of reactive oxygen species, disruption of the mitochondrial
respiratory chain, damage to the bacterial cell wall, altering
DNA and RNA to prevent transcription and division.28
Despite its advantages in treating infected wounds, silver
has been demonstrated to be toxic to the cells involved
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in wound healing process. In study performed by Zoe et
al. all silver dressings tested were found to reduce the vi-
ability of the diabetic fibroblasts and collagen synthesis.25
Other studies have found that silver delays the process of
re-epithelialisation.29, 30 However, the clinical correlation to
support this finding remains unclear. There are increasing
evidence showing that silver toxicity observed in animal and
in vitro models do not seem to play role in vivo.25, 31
Silver in conjunction with NPWT could be used as com-
mercially available foam bonded to metallic silver or typi-
cal NPWT polyurethane foam applied on a silver-containing
dressing which constitute the wound contact layer. Both meth-
ods are widely used because of their antimicrobial ability was
confirmed in vitro32 and on animal models.7 Unfortunately,
there is still a dearth of data confirming their clinical effec-
tiveness. Several authors have demonstrated good outcomes
when applied to infected wounds23, 24, 33 or over split-thickness
skin grafts9, 13, 34 however the majority of these information
goes from case reports or case series which have the lowest
evidence level.17
IV. CONCLUSION
Our experience and data from the literature suggest that
silver dressing in combination with NPWT may contribute to
infection control and exert positive effect on wound healing
and skin grafts intake. However randomize control trial should
be performed to confirm that suspicion.
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